Varalak Srinonprasert
Biographic Data
| ID | 6074829 |
|---|---|
| NAME | Varalak Srinonprasert |
| GIVEN NAMES | Varalak |
| FAMILY NAME | Srinonprasert |
| SIGNATURE | SRINONPRASERT V |
| AFFILIATIONS | Siriraj Hospital |
| ORCID | 0000-0001-5311-7657 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Outcomes of Home Isolation Care Among Covid-19 Patients During the 2021 Epidemic Crisis in the Bangkok Metropolitan Region, Thailand
Objectives. To determine the overall mortality and risk factors of COVID-19 patients who were admitted to the Home Isolation (HI) program in Bangkok, Thailand, during the epidemic crisis in 2021. Methods. We conducted a retrospective cohort study using the data from a government telehealth application from July to December 2021. The vital status was verified from the government database on September 20, 2022. We used survival analysis to analyze …
A cost-utility analysis of BRCA1 and BRCA2 testing in high-risk breast cancer patients and family members in Thailand
Background: variants (gBRCA) in high-risk breast cancer patients is known to be cost-effective in high-income countries. Nationwide adoption of genetics testing in high-risk breast cancer population remains poor. Our study aimed to assess gBRCA health economics data in the middle-income country setting of Thailand. Methods: Decision tree and Markov model were utilized to assess cost-utility between the testing vs. no-testing groups from a societa…
Factors associated with low health-related quality of life among younger and older Thai patients with non-valvular atrial fibrillation
Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in Bhutan
In response to a lack of cost-effective data on screening and early treatment of diabetes and hypertension in resource-limited settings, a model-based economic evaluation was performed on the World Health Organization (WHO)'s Package of Essential Non-communicable (PEN) disease interventions for primary health care in Bhutan. Both local and international data were applied in the model in order to derive lifetime costs and outcomes resulting from t…
No prominent works on this page.
Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in Bhutan
In response to a lack of cost-effective data on screening and early treatment of diabetes and hypertension in resource-limited settings, a model-based economic evaluation was performed on the World Health Organization (WHO)'s Package of Essential Non-communicable (PEN) disease interventions for primary health care in Bhutan. Both local and international data were applied in the model in order to derive lifetime costs and outcomes resulting from t…
Factors associated with low health-related quality of life among younger and older Thai patients with non-valvular atrial fibrillation
A cost-utility analysis of BRCA1 and BRCA2 testing in high-risk breast cancer patients and family members in Thailand
Background: variants (gBRCA) in high-risk breast cancer patients is known to be cost-effective in high-income countries. Nationwide adoption of genetics testing in high-risk breast cancer population remains poor. Our study aimed to assess gBRCA health economics data in the middle-income country setting of Thailand. Methods: Decision tree and Markov model were utilized to assess cost-utility between the testing vs. no-testing groups from a societa…
Outcomes of Home Isolation Care Among Covid-19 Patients During the 2021 Epidemic Crisis in the Bangkok Metropolitan Region, Thailand
Objectives. To determine the overall mortality and risk factors of COVID-19 patients who were admitted to the Home Isolation (HI) program in Bangkok, Thailand, during the epidemic crisis in 2021. Methods. We conducted a retrospective cohort study using the data from a government telehealth application from July to December 2021. The vital status was verified from the government database on September 20, 2022. We used survival analysis to analyze …
Medicine (4 works) · Disease (3 works) · Health Systems, Economic Evaluations, Quality of Life (3 works) · Internal Medicine (3 works) · Cost effectiveness (2 works) · Environmental health (2 works) · Internal Medicine (2 works) · Population (2 works) · Atrial fibrillation (1 work) · Atrial Fibrillation Management and Outcomes (1 work)